Factors associated with quality of life, sleep, and health satisfaction in women with nocturia: a cross-sectional study
Main Article Content
Abstract
Introduction: Nocturia is defined as the number of times urine is passed during the main sleep period. Having woken to pass urine for the first time, each urination must be followed by sleep or the intention to sleep. Objective: To investigate factors associated with quality of life, satisfaction with sleep, and health in women with and without nocturia. Methods: A cross-sectional study involving women attending urogynecology outpatient clinics in Petrópolis and Niterói, RJ, Brazil. Clinical, sociodemographic, and lifestyle data were collected and a physical exam performed. The ICIQ-OAB questionnaire, supplemented by a Visual Analog Scale (VAS), as well as the STOP-BANG and WHOQOL-BREF questionnaires, was administered. Nocturia was defined as one or more voids (nocturia 1) and two or more voids (nocturia 2). Statistical analysis included logistic regression modeling, Wald significance test, Shapiro-Wilk normality test, and Spearman correlation analysis. Results: A total of 131 participants were included. There was a statistically significant association of sensation of incomplete bladder emptying (OR=4.897), multimorbidity (OR=4.621), and the care setting in Petrópolis (OR=0.359) with health satisfaction; caffeine consumption and quality of life (OR=0.994), while sensation of incomplete bladder emptying (OR=2.439) and chronic venous insufficiency (OR=0.437) with sleep satisfaction. The relationship between the number of voids and symptom discomfort was positive for both nocturia 1 and nocturia 2, assessed via numerical scale and VAS. Conclusion: Nocturia had a specific impact on quality of life (QoL). Sensation of incomplete bladder emptying was associated with lower health and sleep satisfaction. Multimorbidity was associated with lower health satisfaction.
Downloads
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License (CC BY) that allows others to share and adapt the work with an acknowledgement of the work's authorship and initial publication in this journal.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.References
1. Hashim H, Blanker MH, Drake MJ, Djurhuus JC, Meijlink J, Morris V, et al. International Continence Society (ICS) report on the terminology for nocturia and nocturnal lower urinary tract function. Neurourol Urodyn. 2019;38(2):499-508. https://doi.org/10.1002/nau.23917
2. Everaert K, Hervé F, Bower W, Djurhuus JC, Dmochowski R, Fine N, et al. How can we develop a more clinically useful and robust algorithm for diagnosing and treating nocturia? ICI‐RS 2017. Neurourol Urodyn. 2018;37(S4):S46-59. https://doi.org/10.1002/nau.23569
3. Offiah I, Drake MJ, Gammie A. Implications of Underactive Bladder Syndrome for Nocturia. Do We Need Urodynamic Assessment? Eur Urol Focus. 2022;8(1):86-8. https://doi.org/10.1016/j.euf.2021.12.013
4. Azuero J, Santander J, Trujillo CG, Caicedo JI, Zuluaga L, Becerra AM, et al. Potential associations of adult nocturia. Results from a national prevalence study. Neurourol Urodyn. 2021;40(3):819-28. https://doi.org/10.1002/nau.24624
5. Soler R, Averbeck MA, Koyama MAH, Gomes CM. Impact of LUTS on treatment‐related behaviors and quality of life: A population‐based study in Brazil. Neurourol Urodyn. 2019;38(6):1579-87. https://doi.org/10.1002/nau.24004
6. Choi EPH, Wan EYF, Kwok JYY, Chin WY, Lam CLK. The mediating role of sleep quality in the association between nocturia and health-related quality of life. Health Qual Life Outcomes. 2019;17(1):181. https://doi.org/10.1186/s12955-019-1251-5
7. Makovski TT, Schmitz S, Zeegers MP, Stranges S, van den Akker M. Multimorbidity and quality of life: Systematic literature review and meta-analysis. Ageing Res Rev. 2019;53:100903. https://doi.org/10.1016/j.arr.2019.04.005
8. Huaquía-Díaz AM, Chalán-Dávila TS, Carrillo-Larco RM, Bernabe-Ortiz A. Multimorbidity in Latin America and the Caribbean: a systematic review and meta-analysis. BMJ Open. 2021;11(7):e050409. https://doi.org/10.1136/bmjopen-2021-050409
9. Pacheco AHRN, Araujo DMR, Lacerda EMA, Kac G. Consumo de cafeína por grávidas usuárias de uma Unidade Básica de Saúde no município do Rio de Janeiro. Rev Bras Ginecol Obstet. 2008;30(5):232-40. https://doi.org/10.1590/s0100-72032008000500005
10. Aziz I, Whitehead WE, Palsson OS, Törnblom H, Simrén M. An approach to the diagnosis and management of Rome IV functional disorders of chronic constipation. Expert Rev Gastroenterol Hepatol. 2020;14(1):39-46. https://doi.org/10.1080/17474124.2020.1708718
11. International Continence Society (ICS). ICS Glossary. Available from: https://www.ics.org/glossary
12. Flynn KE, Wiseman JB, Helmuth ME, Smith AR, Bradley CS, Cameron AP, et al. Comparing clinical bladder diaries and recalled patient reports for measuring lower urinary tract symptoms in the symptoms of Lower Urinary Tract Dysfunction Research Network (LURN). Neurourol Urodyn. 2022;41(8):1711-21. https://doi.org/10.1002/nau.25030
13. Wilson H, Mannix S, Oko-osi H, Revicki DA. The Impact of Medication on Health-Related Quality of Life in Patients with Generalized Anxiety Disorder. CNS Drugs. 2015;29(1):29-40. https://doi.org/10.1007/s40263-014-0217-8
14. Fonseca LBM, Silveira EA, Lima NM, Rabahi MF. STOP-Bang questionnaire: translation to Portuguese and cross-cultural adaptation for use in Brazil. J Bras Pneumol. 2016;42(4):266-72. https://doi.org/10.1590/S1806-37562015000000243
15. Delara M, Murray L, Jafari B, Bahji A, Goodarzi Z, Kirkham J, et al. Prevalence and factors associated with polypharmacy: a systematic review and meta-analysis. BMC Geriatr. 2022;22(1):601. https://doi.org/10.1186/s12877-022-03279-x
16. Brasil. Ministério da Saúde. Secretaria de Atenção à Saúde. Departamento de Atenção Básica. Protocolos do Sistema de Vigilância Alimentar e Nutricional – SISVAN na assistência à saúde. Brasília: Ministério da Saúde, 2008.
17. Madhu C, Swift S, Moloney‐Geany S, Drake MJ. How to use the Pelvic Organ Prolapse Quantification (POP‐Q) system? Neurourol Urodyn. 2018;37(S6):S39-43. https://doi.org/10.1002/nau.23740
18. Fleck MP, Louzada S, Xavier M, Chachamovich E, Vieira G, Santos L, et al. Aplicação da versão em português do instrumento abreviado de avaliação da qualidade de vida “WHOQOL-bref”. Rev Saude Publica. 2000;34(2):178-83. https://doi.org/10.1590/s0034-89102000000200012
19. Pereira SB, Thiel RRC, Riccetto C, Silva JM, Pereira LC, Herrmann V, et al. Validação do International Consultation on Incontinence Questionnaire Overactive Bladder (ICIQ-OAB) para a língua portuguesa. Rev Bras Ginecol Obstet. 2010;32(6):273-8. https://doi.org/10.1590/s0100-72032010000600004
20. Maserejian NN, Kupelian V, McVary KT, Doshi M, Link CL, McKinlay JB. Prevalence of post‐micturition symptoms in association with lower urinary tract symptoms and health‐related quality of life in men and women. BJU Int. 2011;108(9):1452-8. https://doi.org/10.1111/j.1464-410X.2010.10014.x
21. Yoon K, Lee M. Factors influencing the health satisfaction of users of public health and medical institutions in South Korea. Front Public Health. 2023;10:1079347. https://doi.org/10.3389/fpubh.2022.1079347
22. Le Berre M, Presse N, Morin M, Larouche M, Campeau L, Hu YX, et al. What do we really know about the role of caffeine in urinary tract symptoms? A scoping review on caffeine consumption and lower urinary tract symptoms in adults. Neurourol Urodyn. 2020;39(5):1217-33. https://doi.org/10.1002/nau.24344
23. Saraiva SM, Jacinto TA, Gonçalves AC, Gaspar D, Silva LR. Overview of Caffeine Effects on Human Health and Emerging Delivery Strategies. Pharmaceuticals (Basel). 2023;16(8):1067. https://doi.org/10.3390/ph16081067
24. I Y, Karakelle SG, Aydın GT, R M, T O, Iu A. The relationship between clinical severity and outcome measures in patients with chronic venous insufficiency with or without leg ulcer. J Tissue Viability. 2021;30(3):310-16. https://doi.org/10.1016/j.jtv.2021.06.002